Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer

Jemal, A. et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J. Natl Cancer Inst. 105, 175–201 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Gondal, T. A. et al. Anal cancer: the past, present and future. Curr. Oncol. 30, 3232–3250 (2023).

Article  PubMed  PubMed Central  Google Scholar 

James, R. D. et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 14, 516–524 (2013).

Article  CAS  PubMed  Google Scholar 

Glynne-Jones, R. et al. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. Lancet Oncol. 18, 347–356 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Deshmukh, A. A. et al. Incidence trends and burden of human papillomavirus-associated cancers among women in the United States, 2001-2017. J. Natl Cancer Inst. 113, 792–796 (2021).

Article  PubMed  Google Scholar 

Martin, D. et al. Anal squamous cell carcinoma — state of the art management and future perspectives. Cancer Treat. Rev. 65, 11–21 (2018).

Article  PubMed  Google Scholar 

Alemany, L. et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int. J. Cancer 136, 98–107 (2015).

Article  CAS  PubMed  Google Scholar 

Morris, V. K. et al. Clinicopathologic features associated with human papillomavirus/p16 in patients with metastatic squamous cell carcinoma of the anal canal. Oncologist 20, 1247–1252 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner, S. et al. Human papillomavirus-related head and neck cancer. Oncol. Res. Treat. 40, 334–340 (2017).

Article  CAS  PubMed  Google Scholar 

Armstrong, S. A. et al. Molecular characterization of squamous cell carcinoma of the anal canal. J. Gastrointest. Oncol. 12, 2423–2437 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Aldersley, J., Lorenz, D. R., Mouw, K. W., D’Andrea, A. D. & Gabuzda, D. Genomic landscape of primary and recurrent anal squamous cell carcinomas in relation to HPV integration, copy-number variation, and DNA damage response genes. Mol. Cancer Res. 19, 1308–1321 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu, X. et al. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status. Mod. Pathol. 34, 1017–1030 (2021).

Article  CAS  PubMed  Google Scholar 

Hamza, A. et al. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection. Int. J. Cancer 154, 504–515 (2024).

Article  CAS  PubMed  Google Scholar 

Trilla-Fuertes, L. et al. Genetic profile and functional proteomics of anal squamous cell carcinoma: proposal for a molecular classification. Mol. Cell Proteom. 19, 690–700 (2020).

Article  CAS  Google Scholar 

Morris, V. et al. Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal. Mol. Cancer Res. 15, 1542–1550 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung, J. H. et al. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. Ann. Oncol. 27, 1336–1341 (2016).

Article  CAS  PubMed  Google Scholar 

Smaglo, B. G. et al. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget 6, 43594–43604 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Trilla-Fuertes, L. et al. Comprehensive characterization of the mutational landscape in localized anal squamous cell carcinoma. Transl. Oncol. 13, 100778 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Iseas, S. et al. A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma. Transl. Oncol. 14, 101084 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glaviano, A. et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer 22, 138 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cacheux, W. et al. Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection. Br. J. Cancer 114, 1387–1394 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin, M. K. et al. Activating mutations in Pik3ca contribute to anal carcinogenesis in the presence or absence of HPV-16 oncogenes. Clin. Cancer Res. 25, 1889–1900 (2019).

Article  CAS  PubMed  Google Scholar 

De Vuyst, H., Clifford, G. M., Nascimento, M. C., Madeleine, M. M. & Franceschi, S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer 124, 1626–1636 (2009).

Article  PubMed  Google Scholar 

Meulendijks, D. et al. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Br. J. Cancer 112, 1358–1366 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernardi, M. P. et al. Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention. Lancet Oncol. 16, e611–e621 (2015).

Article  CAS  PubMed  Google Scholar 

Mouw, K. W. et al. Genomic evolution after chemoradiotherapy in anal squamous cell carcinoma. Clin. Cancer Res. 23, 3214–3222 (2017).

Article  CAS  PubMed  Google Scholar 

Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189–193 (2014).

Article  CAS  PubMed  Google Scholar 

Tchelebi, L. T. et al. Current treatment and future directions in the management of anal cancer. CA Cancer J. Clin. 72, 183–195 (2022).

Article  PubMed  Google Scholar 

Shao, C. et al. Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors. JAMA Netw. Open 3, e2025109 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Salem, M. E. et al. Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers. Mol. Cancer Res. 16, 805–812 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prete, A. A. et al. Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: translational analyses of the “CARACAS” study. Eur. J. Cancer 182, 87–97 (2023).

Article  CAS 

Comments (0)

No login
gif